Vous êtes ici : Accueil > Projet ApneaBand

Europe | Santé ＆ sciences du vivant | Nouvelles technologies


ApneaBand

​Sleep Apnea Diagnostic and Monitoring. Sleep disorder-related breathing is associated with many major chronic diseases (obesity,cancer, etc.) and remains widely underdiagnosed. ApneaBand is a non-intrusivemedical screening method combining a wristband and AI software for home detection of Obstructive Sleep Apnea (OSA).


Publié le 22 avril 2021

​


ApneaBand : Sleep Apnea Diagnostic and Monitoring

Sleep disorder-related breathing is associated with many major chronic diseases (obesity, cancer, etc.) and remains widely underdiagnosed. ApneaBand is a non-intrusive medical screening method combining a wristband and AI software for home detection of Obstructive Sleep Apnea (OSA).




 

Starting date : Jan 2018 > Dec 2018    Lifetime:12 months


Program in support : 

 

Status project : complete


CEA-Leti's contact :Laurent Gerfault                                        

                                               

 

Project Coordinator: CEA-Leti 


Partners:  

  • Agencia de Qualitat i Avaluacio (Es)

  • Sanitaries de Catalunya,(Es)

  • Universitat de Barcelona, (Es)

  • Airfan, Université Grenoble Alpes, (Fr)

​Target market: n/a

​

Investment:  € 0.5 m.

EC Contribution: € 0.5 m.


Website


Stakes

  • ApneaBand has been validated under the CEA-Leti program of trials dedicated to home-based sleep apnea testing. 

  • Thirty-seven patients spent no fewer than 74 nights with ApneaBand during clinical trials. These patients used the device under real life domestic conditions and their output data was processed by a clinical team using it for the first time. ApneaBand has received positive feeback on usage from professionals and patients. Its im­pact on sleep quality is low, unlike the current reference system. 

  • A market study has shown that the ApneaBand concept is attractive for sleep apnea management in the countries, in which trials were conducted. Its cutting edge technical features include:
  1. Electronic designSupporting acquisition software
  2. An automatic detection algorithm 
  3. A web-based interface dedicated to medical review of results. 


  • Technical partner Airfan is committed to the solution's CE marking certification in conjunction with the CEA-Leti team.



OBJECTIVES

  • The ApneaBand project adapts and validates a wearable solution dedicated to respiratory sleep disorder event detection from device hardware to business plan. Validation of our solution (device + post processing software) has been based on clinical validation, usage validation and market validation. Adaptation of our solution to the market has been performed (for software and hardware following updated specifications) in relation to penetration strategy by a market study and to regulation rules by a market access study. Communications and solution testing have been conducted in relation to patients and professio­nals, stakeholders and the general population. 



IMPACT

  • ApneaBand is a disruptive technology for screening/diagnosing OSA in high risk patients not suffering from another form of sleep disorder-related breathing. ApneaBand TRL status has been upgraded and its performance characteristics have been initially evaluated during home trials. Partner Airfan has launched ApneaBand industrialisation and final CE marking.